HWAIL PHARM. CO., LTD Korea Bond Investment Management reports new 12.53% stake via convertible bond acquisition
HWAIL PHARM. CO., LTD· Report on Large Shareholdings
HAI summary · Not investment advice
Korea Bond Investment Management newly reported a 12.53% stake, holding 1,205,690 shares through a convertible bond acquisition.
Stake
12.53%
New report
Key facts
- Reporting obligation date
- Oct 8, 2026
Show Korean comments
Comments
No comments yet
Comments from shareholders will appear here.
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist